Substance-encapsulating vesicle and process for producing the same
US-10357454-B2 · Jul 23, 2019 · US
US12544334B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12544334-B2 |
| Application number | US-201917046953-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 11, 2019 |
| Priority date | Apr 13, 2018 |
| Publication date | Feb 10, 2026 |
| Grant date | Feb 10, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present application relates to pH-sensitive polymersomes. The polymersomes are capable of degradation at endosomes' mild acidic pH into resorbable materials, which also allows avoiding liposome premature degradation of the payload once internalised inside the cells. The polymersomes can thus be used in methods for the treatment or prevention of diseases.
Opening claim text (preview).
The invention claimed is: 1 . A polymersome that comprises: (a) a protein repellent polymer; and (b) a pH sensitive biodegradable succinate polymer comprising (i) succinate monomeric units in the polymer backbone, and (ii) a pendant group with a pKa of from 6.2 to 7, wherein the pendant group comprises an imidazole moiety. 2 . The polymersome of claim 1 , wherein the protein repellent polymer is an acrylate polymer, a polypeptide, a polyester, a polyamide, a polyanhydride, a polyurethane, a polyether, a polyimine, a polyurea, a polyacetal, a polysaccharide or a polycarbonate. 3 . The polymersome of claim 2 , wherein the protein repellent polymer comprises units of formula (I) in which R p is hydrogen or methyl and A p is a group of formula (I′) in which X p is a C 1-6 alkylene group. 4 . The polymersome of claim 1 , wherein the protein repellent polymer is poly (2-(methacryloyloxy) ethyl phosphorylcholine) or poly (ethylene oxide). 5 . The polymersome of claim 1 , wherein the imidazole moiety is imidazole, methylimidazole or dimethylimidazole. 6 . The polymersome of claim 1 , wherein the pH sensitive biodegradable succinate polymer is poly[propylene 2-((2-(2-(1H-imidazol-5-yl) acetamido)-3-(tert-butoxy)-3-oxopropyl) thio) succinate]. 7 . The polymersome of claim 1 , which further comprises a drug encapsulated within the polymersome. 8 . A pharmaceutical composition comprising: a plurality of the polymersomes of claim 1 ; and one or more pharmaceutically acceptable excipients or diluents. 9 . A method that comprises administering the polymersome of claim 1 to a subject. 10 . A method that comprises: (i) administering the polymersome of claim 7 to a subject; and (ii) releasing the drug in vivo in the subject.
Manufacture or treatment of nanostructures · CPC title
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title
Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.